Status:
UNKNOWN
Comparison of Efficacy of ESWL and Laser Lithotripsy in Chronic Pancreatitis With ERCP
Lead Sponsor:
Changhai Hospital
Conditions:
Pancreatitis, Chronic
Pancreatic Duct Stone
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This study will compare the efficacy of ESWL and Laser Lithotripsy in the treatment of pancreatic duct stones with ERCP.
Detailed Description
Chronic pancreatitis (CP) is an inflammatory disease that can causes progressive fibrosis of pancreatic tissue and eventually leads to damage of pancreatic exocrine and endocrine. According to statist...
Eligibility Criteria
Inclusion
- symptomatic adult patients diagnosed with chronic pancreatitis and pancreatic duct stones;
- at least one stone (\>5 mm in diameter) located in the pancreatic duct of the head/body of the pancreas;
- dilation of the proximal pancreatic duct.
Exclusion
- history of ERCP or ESWL treatment;
- suspected to have malignant tumors;
- history of pancreatic surgery or gastrojejunostomy (Billroth II);
- pancreatic pseudocyst with a diameter \>4cm;
- bile duct stricture secondary to cholangitis or chronic pancreatitis;
- acute pancreatitis exacerbation or acute exacerbation of chronic pancreatitis (including biliary pancreatitis);
- coagulation dysfunction (INR≥1.5 or platelet count≤50×10\^9/L);
- pregnant or breastfeeding women;
- patients who refused to participate in the study.
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05326542
Start Date
September 1 2022
End Date
December 1 2022
Last Update
September 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, China, 200433